Drug side effects
plazomicin Side Effects
The reactions most often reported to the FDA for plazomicin (also sold as Zemdri), with demographics, serious outcomes, and reporting trends.
Data updated 2026-05-15
- 3
- FAERS reports
Data from the FDA Adverse Event Reporting System (FAERS), 2021 to 2022. A FAERS report records a temporal association, not proof of cause. See our methodology for how figures are compiled and de-duplicated.
The most commonly reported side effects of plazomicin come from 3 reports to the FDA, broken down here by frequency, patient demographics, and serious outcomes.
This page analyzes 3 reports to the FDA Adverse Event Reporting System (FAERS) for plazomicin (Zemdri): the reactions reported most often, who reported them, serious outcomes such as hospitalization, and year-over-year trends. A FAERS report does not prove the drug caused the effect, and report volume tracks how widely a drug is used, not how likely an effect is for any one person. Educational information, not medical advice.
Total Reports
3
Hospitalizations
1
33.3% of reports
Top Indication
Infusion
Most Reported Adverse Reactions
Who Reports Side Effects
Gender Distribution
Age Distribution
Reporting Trend by Year
Reactions in Hospitalization Reports
Top reactions in 1 reports where hospitalization was an outcome.
| Reaction | Reports |
|---|---|
| CREATININE RENAL CLEARANCE DECREASED | 1 |
| RENAL FAILURE | 1 |
Nearby, Related Medications
What the FAERS Data Reveals About plazomicin Side Effects
The FDA Adverse Event Reporting System (FAERS) contains 3 voluntary reports linked to plazomicin and its brand equivalents (Zemdri), spanning 2021 through 2022. No reports in this dataset listed death as an outcome and 1 (33.3%) involved hospitalization. The most common indication reported alongside adverse events was Infusion.
Demographic breakdowns help contextualize who is being exposed to the drug. Of reports with known sex, 0% were female and 100% male; age distribution skews toward 18-44, with 1 report in that bracket. The single most reported reaction is acute kidney injury with 1 submission, followed by antibiotic level above therapeutic and creatinine renal clearance decreased.
How to read these numbers
FAERS is a signal-detection tool, not a scorecard. Reports are voluntary, and a single case may list multiple suspect drugs, so numbers above should not be read as incidence rates or per-patient risk. Widely prescribed drugs naturally accumulate more reports than niche therapies even when individual risk is low. These aggregates are useful for spotting patterns that merit further pharmacovigilance, not for choosing between medications. This page is for educational reference only and is not medical advice, speak with a licensed clinician about any side-effect concerns.
Drugs With a Similar FAERS Report Volume
Other medications with a total FDA adverse-event report count closest to plazomicin's 3.
Read our methodology - how this data is sourced, computed, and verified.